Chris Champlin – Vice President & General Manager for the Growth, Protection and Separations business unit of Thermo Fisher Scientific
Thermo Fisher is at the heart of the global response to COVID-19. They are working with government agencies and researchers to ensure priority access to instruments, consumables, safety supplies and other products to address the outbreak–particularly in analysis of the virus, diagnosis and personal protection. From clinical trials, manufacturing, PPP, to storage resources, channel management and more, they are a key player for all facets of protection, testing and eventually, vaccinations.
Chris Champlin is currently Vice President & General Manager for the Growth, Protection and Separations business unit of Thermo Fisher Scientific. Chris has held several global positions of increasing responsibility at Thermo Fisher. In each of his roles Chris has been an instrumental player in multiple acquisitions and divestitures, with an area of expertise in the integration of global commercial organizations. Additional responsibilities have included Director, North American Repository Operations, based in Rockville, MD. Director of European Commercial Product Management for the Laboratory Products Group based in Basingstoke, UK, and Director of Global Commercial Management for the Growth and Protection Business unit. Prior to his current role Chris was the Vice President Commercial North American Sales and Customer Service Operations for the Lab Equipment Division as well as Vice President & General Manager for Thermo Fisher’s Controlled Temperature Technologies Business Unit. For the past four years Chris served as the Vice President of the Global Corporate Accounts program transforming the groups approach to Global Pharma and Biotech.
